TGFB1 and neoplasm: Tumor-derived proteases like matrix metalloproteinases (MMPs), prostate-specific antigen (PSA), or urokinase-type plasminogen activator (uPA) contribute to the release of osteoblastic factors from the extracellular matrix, including TGF-β and IGF-I [30].